Alibaba Health stock trades 2.2 percent above its yearly low

Published on 10/07/2026 at 06:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alibaba Health stock stood at HKD 2.81 on October 7, 2026, only 2.2 percent above its 52-week low. UOB Kay Hian cut its target to HKD 4.00.

Alibaba Health, BMG0171K1018, Illustration mit AI erstellt.

Alibaba Health stock (ISIN BMG0171K1018) was trading at HKD 2.81 on the Hong Kong Stock Exchange on October 7, 2026, 2.2 percent above its 52-week low of HKD 2.75. The central issue is growth discipline after UOB Kay Hian lowered the company's FY27 revenue growth target to 7-10 percent from 10-15 percent on September 21, 2026.

Growth target moves lower

According to UOB Kay Hian on September 21, 2026, Alibaba Health kept its adjusted FY27 net profit guidance at RMB 1.9 billion-2.3 billion while reducing the revenue growth target. The research house maintained a Buy rating but lowered its price target from HKD 5.20 to HKD 4.00.

The change points to a deliberate shift away from subsidy-led volume growth. UOB Kay Hian said savings from lower product-price subsidies would be redirected toward B2C and O2O supply-chain integration, while drug categories remain the main growth engine and non-drug categories are guided for low single-digit growth.

Profit growth remains visible

Alibaba Health reported fiscal year 2026 revenue of HKD 34.255 billion, compared with HKD 30.598 billion in fiscal year 2025, a 12.0 percent increase, according to Reuters. Net income rose to HKD 1.936 billion from HKD 1.432 billion over the same periods, an increase of 35.2 percent.

The earnings mix matters because the lower FY27 revenue target does not come with a lower adjusted profit range in the UOB Kay Hian update. For investors, the test is whether supply-chain investment can preserve profitability as subsidy support becomes less central to customer acquisition.

Consensus target stays above price

Investing.com lists a Buy consensus from 15 analysts, with an average 12-month price target of HKD 4.50, a high target of HKD 7.65566479 and a low target of HKD 2.79962547. Against the October 7 price of HKD 2.81, the average target lies 60.1 percent above the price.

Stock holds near yearly low

Alibaba Health was trading at HKD 2.81 at 11:50 a.m. HKT on October 7, 2026, down HKD 0.03 or 0.88 percent from the prior close. The day's range was HKD 2.79 to HKD 2.85, volume was 11,748,004 shares and market capitalization was HKD 45.4 billion.